For most candidates, GLP-1 therapy represents a favorable risk-benefit profile when monitored appropriately
Imran M, Saeed F, Hussain G, Imran A, Mehmood Z, Gondal TA, El-Ghorab A, Ahmad I, Pezzani R, Arshad MU, Bacha U, Shariarti MA, Rauf A, Muhammad N, Shah ZA, Zengin G, Islam S (2021) Myricetin: a comprehensive review on its biological potentials
GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity. Journal of Clinical Endocrinology & Metabolism, vol
Research is under way on the effectiveness of treating addiction with these medications, and some initial studies have shown promising results
Ophthalmic Paediatr Genet